CINECA IRIS Institutional Research Information System

TORREGROSSA, LIBORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.033
AS - Asia 4.875
EU - Europa 4.004
SA - Sud America 769
AF - Africa 369
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 19.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.811
SG - Singapore 1.648
IT - Italia 1.282
CN - Cina 1.267
HK - Hong Kong 750
DE - Germania 642
BR - Brasile 640
SE - Svezia 557
VN - Vietnam 446
AT - Austria 298
GB - Regno Unito 279
BG - Bulgaria 205
FR - Francia 192
CI - Costa d'Avorio 165
FI - Finlandia 159
IN - India 144
TR - Turchia 138
CA - Canada 127
RU - Federazione Russa 122
JP - Giappone 121
SN - Senegal 77
BD - Bangladesh 56
KR - Corea 53
NL - Olanda 47
PL - Polonia 45
AR - Argentina 44
IQ - Iraq 43
MX - Messico 41
ZA - Sudafrica 37
PK - Pakistan 32
UA - Ucraina 30
MA - Marocco 28
SA - Arabia Saudita 27
ES - Italia 26
ID - Indonesia 26
NG - Nigeria 25
EC - Ecuador 23
UZ - Uzbekistan 18
CZ - Repubblica Ceca 16
VE - Venezuela 16
BE - Belgio 13
CH - Svizzera 13
CO - Colombia 13
EE - Estonia 13
LT - Lituania 13
IR - Iran 12
JO - Giordania 12
IE - Irlanda 11
KE - Kenya 11
NP - Nepal 11
PH - Filippine 11
PE - Perù 9
PY - Paraguay 9
CL - Cile 8
GR - Grecia 8
HU - Ungheria 8
PA - Panama 8
DO - Repubblica Dominicana 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
EU - Europa 6
HN - Honduras 6
JM - Giamaica 6
MY - Malesia 6
PS - Palestinian Territory 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
KZ - Kazakistan 5
OM - Oman 5
GT - Guatemala 4
IL - Israele 4
UY - Uruguay 4
BY - Bielorussia 3
CY - Cipro 3
GD - Grenada 3
LK - Sri Lanka 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 19.042
Salva come PNG Salva come JPEG
Città #
Dallas 1.129
Ashburn 1.087
Singapore 933
Hong Kong 737
San Jose 712
Chandler 649
Fairfield 566
Santa Clara 535
Woodbridge 384
Shanghai 282
Houston 281
Milan 277
Seattle 271
Vienna 265
New York 250
Beijing 241
Ann Arbor 218
Sofia 203
Wilmington 200
Cambridge 199
Los Angeles 195
Abidjan 165
Boardman 147
Pisa 143
Munich 141
Ho Chi Minh City 134
Florence 121
Serra 119
Princeton 117
Tokyo 109
Lawrence 97
Lauterbourg 93
Frankfurt am Main 84
London 83
Medford 82
Hanoi 81
Dakar 77
Hefei 72
Turku 65
Ottawa 60
Rome 60
São Paulo 59
Istanbul 58
Council Bluffs 55
Helsinki 52
San Diego 52
Seoul 46
Redondo Beach 45
Buffalo 43
Bremen 39
Cascina 37
Nanjing 33
Izmir 32
Des Moines 31
Dong Ket 31
Ogden 29
Orem 29
Warsaw 29
Vicopisano 28
Poplar 26
Belo Horizonte 24
Redmond 24
Chicago 23
Atlanta 22
Lagos 22
Düsseldorf 21
Johannesburg 21
Montreal 21
Paris 21
Rio de Janeiro 21
Boulder 20
Phoenix 20
Amsterdam 19
Columbus 19
Nuremberg 19
Brooklyn 18
Fuzhou 18
Haiphong 18
Manchester 18
Brasília 17
Hyderabad 17
Lancaster 17
Lucca 17
Tashkent 17
Ankara 16
Chennai 16
Guangzhou 16
Naples 16
Quanzhou 16
Toronto 16
Baghdad 15
Dearborn 15
Denver 15
Norwalk 14
Casablanca 13
Mumbai 13
Stockholm 13
Zhengzhou 13
Amman 12
Brussels 12
Totale 13.123
Salva come PNG Salva come JPEG
Nome #
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 273
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 251
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 239
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 234
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 231
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 223
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 221
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 220
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 217
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 213
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 211
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 206
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 202
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 201
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 193
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 187
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 187
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 186
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 186
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 182
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 182
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 178
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 178
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 176
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 176
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 175
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 175
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 175
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 175
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 175
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 173
Impact of energy-based devices in pediatric thyroid surgery 172
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 171
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 170
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 170
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 169
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 166
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 165
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 165
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 163
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 162
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 162
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 162
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 162
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 161
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 161
null 160
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 160
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 160
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 159
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 157
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience 157
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 157
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 156
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 155
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 155
A large functioning parathyroid lipoadenoma 153
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 153
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. 153
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 153
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 152
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 152
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 152
COVID-19 autopsy cases: detection of virus in endocrine tissues 150
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 149
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements 149
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 147
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 147
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 146
An adrenal cortical adenoma with neuroendocrine-type granules mimicking pheochromocytoma 145
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 142
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 142
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 141
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 140
Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies 139
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis 139
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 138
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 135
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 134
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma 134
CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1 132
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 132
High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience 130
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 128
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 128
Galectin-3 is highly expressed in nonencapsutated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothetial cell 1 immunoreactivity 127
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 126
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 124
Correlation of the presurgical diagnosis of follicular variant of papillary thyroid cancer with the disease status after 10 years of follow-up. 124
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 123
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease 122
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 121
Molecular genetics of follicular-derived thyroid cancer 120
Atypical parathyroid adenomas: Challenging lesions in the differential diagnosis of endocrine tumors 119
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions 119
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 118
Follicular (FVPTC) VS Classical (CVPTC) variant of papillary thyroid cancer: correlation of the outcome after 12 years of follow up. 116
Firm mass in thyroid of an elderly patient: Not always cancer 113
Totale 16.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021184 0 0 0 0 0 0 0 0 0 0 77 107
2021/20221.189 27 24 41 47 195 222 55 42 72 62 103 299
2022/20232.332 221 343 194 198 248 253 29 185 464 11 152 34
2023/20241.465 117 130 191 168 175 260 73 35 29 39 107 141
2024/20254.521 46 143 59 257 446 443 369 203 454 519 493 1.089
2025/20266.348 437 882 937 694 690 430 941 297 333 669 38 0
Totale 19.416